Osteoporosis medication adherence is poor

Share this article:
Adherence to osteoporosis medications is relatively poor, according to recent article in the journal Drugs & Aging. About 20% to 30% of patients taking daily or weekly treatments may suspend use within six to 12 months of initiating therapy, a study appearing in the January issue said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.